Metropolitan Life Insurance Company (MetLife)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,295	Closed	-$105K	–	2533
2017 Q4	$105K	Buy	+4,295	New	+$82.6K	﹤0.01%	2287

Metropolitan Life Insurance Company (MetLife)'s ENTL Position: Q1 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 4,295 shares — an estimated $105K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $105K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 4,295 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $105K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s Entellus Medical, Inc. Common Stock position peaked at $105K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.